[1] |
WHO. WHO Guidelines for Treatment of Cervical Intraepithelial Neoplasia 2–3 and Adenocarcinoma in situ:Cryotherapy,Large Loop Excision of the Transformation Zone,and Cold Knife Conization [M]. Geneva:World Health Organization,2014:1-2.
|
[2] |
LI K M, YIN R T, LI Q L,et al. Analysis of HPV distribution in patients with cervical precancerous lesions in Western China[J]. Medicine(Baltimore), 2017, 96(29):e7304. DOI: 10.1097/MD.0000000000007304.
|
[3] |
|
[4] |
LOOPIK D L, BENTLEY H A, EIJGENRAAM M N,et al. The natural history of cervical intraepithelial neoplasia grades 1,2,and 3:a systematic review and meta-analysis[J]. J Low Genit Tract Dis, 2021, 25(3):221-231. DOI: 10.1097/LGT.0000000000000604.
|
[5] |
KENYA S, CARRASQUILLO O, FATIL M,et al. Human Papilloma virus and cervical cancer education needs among HIV-positive Haitian women in Miami[J]. Womens Health Issues, 2015, 25(3):262-266. DOI: 10.1016/j.whi.2014.12.007.
|
[6] |
KLÜGEL S, LÜCKE C, MEHREN A,et al. Patients with cervical intraepithelial neoplasms show different states of health-related quality of life and different coping styles depending on the choice of therapy:findings from the CIN study[J]. Int J Womens Health, 2019, 11:511-517. DOI: 10.2147/IJWH.S208257.
|
[7] |
FREGNANI C M S, FREGNANI J H T G, PAIVA C E,et al. Translation and cultural adaptation of the Functional Assessment of Chronic Illness Therapy - Cervical Dysplasia(FACIT-CD)to evaluate quality of life in women with cervical intraepithelial neoplasia[J]. Einstein(Sao Paulo), 2017, 15(2):155-161. DOI: 10.1590/S1679-45082017AO3910.
|
[8] |
|
[9] |
罗健. 脑卒中患者QOL研究及其MCID制定[D]. 昆明:昆明医科大学,2017.
|
[10] |
杨铮. 癌症患者生命质量测定量表共性模块(V2.0)研制及最小临床有意义差异制定[D]. 广州:南方医科大学,2015.
|
[11] |
ÇELIK D, ÇOBAN Ö, KILIÇOGLU Ö. Minimal clinically important difference of commonly used hip-,knee-,foot-,and ankle-specific questionnaires:a systematic review[J]. J Clin Epidemiol, 2019, 113:44-57. DOI: 10.1016/j.jclinepi.2019.04.017.
|
[12] |
|
[13] |
FACIT.Org. FACIT [EB/OL].[2022-04-25].
|
[14] |
|
[15] |
胡欣. EQ-5D-5L量表应用于宫颈癌前病变患者的测量学特性及MCID研究[D]. 石河子:石河子大学,2020.
|
[16] |
李晓静. COPD患者QOL研究及其MCID的制定[D]. 昆明:昆明医科大学,2019.
|
[17] |
LUO N, LIU G, LI M H,et al. Estimating an EQ-5D-5L value set for China[J]. Value Health, 2017, 20(4):662-669. DOI: 10.1016/j.jval.2016.11.016.
|
[18] |
MYINT OO K Z, FUEKI K, INAMOCHI Y,et al. Pre-treatment impairment of oral health-related quality of life is associated with variations in minimal clinically important differences among patients with removable partial denture treatment[J]. J Oral Rehabil, 2020, 47(7):902-909. DOI: 10.1111/joor.12980.
|
[19] |
REBELO P, OLIVEIRA A, PAIXÃO C,et al. Minimal clinically important differences for patient-reported outcome measures of cough and sputum in patients with COPD[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15:201-212. DOI: 10.2147/COPD.S219480.
|
[20] |
HU X, JING M X, ZHANG M,et al. Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia:a longitudinal study[J]. Health Qual Life Outcomes, 2020, 18(1):324. DOI: 10.1186/s12955-020-01578-8.
|
[21] |
SEDAGHAT A R. Understanding the minimal clinically important difference(MCID)of patient-reported outcome measures[J]. Otolaryngol Head Neck Surg, 2019, 161(4):551-560. DOI: 10.1177/0194599819852604.
|
[22] |
MOLINO J, HARRINGTON J, RACINE-AVILA J,et al. Deconstructing the minimum clinically important difference(MCID)[J]. Orthop Res Rev, 2022, 14:35-42. DOI: 10.2147/ORR.S349268.
|
[23] |
MILLS K A, NAYLOR J M, EYLES J P,et al. Examining the minimal important difference of patient-reported outcome measures for individuals with knee osteoarthritis:a model using the knee injury and osteoarthritis outcome score[J]. J Rheumatol, 2016, 43(2):395-404. DOI: 10.3899/jrheum.150398.
|
[24] |
SU F, ALLAHABADI S, BONGBONG D N,et al. Minimal clinically important difference,substantial clinical benefit,and patient acceptable symptom state of outcome measures relating to shoulder pathology and surgery:a systematic review[J]. Curr Rev Musculoskelet Med, 2021, 14(1):27-46. DOI: 10.1007/s12178-020-09684-2.
|
[25] |
杨丽虹,刘少南,吴大嵘,等. 最小临床意义差值的概念及其估算方法[J]. 中国循证医学杂志,2020,20(11):1345-1352.
|
[26] |
JAYADEVAPPA R, COOK R, CHHATRE S. Minimal important difference to infer changes in health-related quality of life-a systematic review[J]. J Clin Epidemiol, 2017, 89:188-198. DOI: 10.1016/j.jclinepi.2017.06.009.
|
[27] |
|
[28] |
|
[29] |
李桐. 体质指数对健康相关生命质量的影响——不同运动水平的分层分析[D]. 北京:北京中医药大学,2018.
|
[30] |
ALMA H, DE JONG C, JELUSIC D,et al. Baseline health status and setting impacted minimal clinically important differences in COPD:an exploratory study[J]. J Clin Epidemiol, 2019, 116:49-61. DOI: 10.1016/j.jclinepi.2019.07.015.
|
[31] |
SCHULLER W, OSTELO R W, JANSSEN R,et al. The influence of study population and definition of improvement on the smallest detectable change and the minimal important change of the neck disability index[J]. Health Qual Life Outcomes, 2014, 12:53. DOI: 10.1186/1477-7525-12-53.
|